IMMUNITOR

immunitor-logo

Since 2000, Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, cancer; and atherosclerosis/obesity. Immunitor Inc. is the global holding corporation for Immunitor product and manufacturing rights and assets. Currently, Immunitor has GMP manufacturing capability in Thailand. Specific Immunitor products are registered in several Asian and African countries. Immunitor CEO is Dr. Aldar S. Bourinbaiar, the manufacturing plant is run by Mr. Vichai Jirathitikal. These two individuals are the respective main shareholders of the company.

#People #Website #More

IMMUNITOR

Industry:
Biotechnology Health Care Pharmaceutical Therapeutics

Founded:
2000-01-01

Address:
Chachoengsao, Chachoengsao, Thailand

Country:
Thailand

Website Url:
http://www.immunitor.com

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
SPF Apache PHP DigiCert SSL CentOS Apache 2.2 RapidSSL Thickbox


Current Employees Featured

vichai-jirathitikal_image

Vichai Jirathitikal
Vichai Jirathitikal Owner @ Immunitor
Owner

aldar-bourinbaiar_image

Aldar Bourinbaiar
Aldar Bourinbaiar CEO @ Immunitor
CEO
2001-01-01

Founder


aldar-bourinbaiar_image

Aldar Bourinbaiar

vichai-jirathitikal_image

Vichai Jirathitikal

Official Site Inspections

http://www.immunitor.com Semrush global rank: 5.31 M Semrush visits lastest month: 1.56 K

  • Host name: cp1.hostsilo.com
  • IP address: 64.187.97.201
  • Location: Fort Lauderdale United States
  • Latitude: 26.0989
  • Longitude: -80.182
  • Metro Code: 528
  • Timezone: America/New_York
  • Postal: 33308

Loading ...

More informations about "Immunitor"

Immunitor - Crunchbase Company Profile & Funding

Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, …See details»

Immunitor 2025 Company Profile: Valuation, Investors ... - PitchBook

Immunitor General Information Description. Manufacturer and developer of immunotherapies and therapeutic vaccines intended for the treatment of tuberculosis. The company is engaged in …See details»

IMMUNITOR INC. - VANCOUVER BC CANADA - Companies of …

Immunitor Inc. is governed under the Canada Business Corporations Act - 2010-09-09. It a company of type: Non-distributing corporation with 50 or fewer shareholders. The date of the …See details»

Immunitor: Contact Details and Business Profile - RocketReach

Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad-spectrum bacterial and fungal infections, …See details»

Immunitor Inc. | Vancouver, BC, Canada Startup - Gust

Immunitor is a global oral vaccine corporation. For two decades, many successful clinical trials are published in peer-reviewed journals. The most recent Hepko-V5 (hepcortespenlisimut-L, for …See details»

Immunitor Company Profile | Management and Employees List

Immunitor Profile and History Since 2000 Immunitor has been developing orally-delivered immunotherapies for a number of serious diseases affecting the world. Immunitor products are …See details»

Immunitor - Overview, News & Similar companies | ZoomInfo.com

Feb 1, 2020 Immunitor products are used as means of preventing and/or treating viral infections such as HIV, hepatitis B and C, influenza, tuberculosis, broad spectrum bacterial and fungal …See details»

Immunitor - Products, Competitors, Financials, Employees, …

Immunitor focuses on the development of orally-delivered immunotherapies within the pharmaceutical industry. Use the CB Insights Platform to explore Immunitor's full profile. …See details»

Immunitor, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Sign Up for Free. Last update 23 Jan 2025See details»

Immunitor - Crunchbase

Immunitor develops orally-delivered immunotherapies for a number of serious diseases affecting the world.See details»

Immunitor, Inc.:Company Profile & Technical Research,Competitor …

Immunitor was founded in 2000. and was founded by Aldar Bourinbaiar, Aldar Bourinbaiar, Vichai Jirathitikal, Vichai Jirathitikal. Immunitor has a total of 2 patents . Related Topics. Pharmacy …See details»

Immunitor - Contacts, Employees, Board Members, Advisors

Organization. Immunitor . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. Immunitor has 2 current …See details»

Aldar S. Bourinbaiar | Walsh Medical Media | 3660

Immunitor USA Inc. USA Biography. Aldar S. Bourinbaiar is CEO of Immunitor USA Inc., manufacturer and developer of oral vaccines. ... Elected as Thailands regional representative …See details»

Immunitor, Inc. (Immunitor, Inc.) - 药物管线_专利_临床试验_投融营 …

Keytruda for example, aside from its high cost, only has a 10% positive response rate in 12-month HCC treatments. Breakthrough Liver Cancer Treatment Immunitor V5 has demonstrated …See details»

Welcome to immunitor.com

Welcome to immunitor.com This domain is parked free of charge with NameSilo.com. NameSilo offers the cheapest domains on the Internet as well as:See details»

Immunitor - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Immunitor develops orally-delivered immunotherapies for a number of serious diseases affecting the world. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»

Immunitor publishes interim results from Phase III trial of oral ...

Feb 1, 2020 Canada-based Immunitor is a private biopharmaceutical company with affiliations in USA, Russia, China, Hong Kong, Ukraine, Mongolia and South Africa. Immunitor has …See details»

Immunitor's breakthrough in cancer immunotherapy

Jun 25, 2014 Immunitor Inc., reported that company's first proof-of-concept clinical study of its candidate cancer vaccine in patients with terminal stage of liver cancer has been presented at …See details»

Immunitor USA Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore Immunitor USA Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, and 12 literature, Drug:Antimicrobial vaccine (Immunitor USA), Antifungal vaccine …See details»

V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data. Immunitor LLC ... Immunitor LLC. Ulaanbaatar, , Site Contact. Aldar …See details»